Shaping the future of IVF technology with expert transaction support

We’ve supported Matcher Technologies Limited (IMT Matcher) in pursuing strategic partnership with ReproTech LLC, creating a global leader in IVF treatment technology. Our corporate experts advised throughout the entire transaction, which included the design and execution of a competitive bidding process and comparative analysis of each proposal.

At the forefront of global fertility tech innovation

IMT Matcher provides IVF management technologies and quality management systems to fertility clinics, donor banks and other assisted reproductive technology centres globally.

For over two decades, IMT Matcher has been at the forefront of innovation in fertility treatment technology, having introduced the first-ever electronic witnessing system. Its advanced software enhances traceability and safeguards IVF procedures by minimising the risks of human error, while also improving operational efficiency in fertility clinics.

IMT Matcher has been a valued client of ours for nearly two decades, during which time we have had the privilege of advising both the company’s founder, Tim Heywood, and his successor, George Heywood.

Enabling a seamless transition

Over the years, IMT Matcher established itself as a global leader in the fertility and reproductive technology field, and the shareholders ultimately decided that the time was right to pursue a strategic partnership — one that would not only provide an exit opportunity, but also ensure the continued growth and success of the business.

We were instructed to advise on the full lifecycle of the transaction, including the design and execution of a competitive bidding process.

Following this, ReproTech LLC emerged as the preferred bidder. Based in Delaware, ReproTech is a leading provider of advanced cryostorage technologies, offering comprehensive off-site storage and logistics solutions.

The company collaborates with fertility clinics, hospital networks, donor banks and andrology laboratories to deliver secure, state-of-the-art preservation of reproductive materials, including sperm, oocytes, embryos, stem cells and oncofertility-related tissues.

Commercially-driven advice during the full transaction lifecycle

We provided strategic guidance throughout, including a comparative analysis of competing bid proposals, ensuring that the shareholders were equipped to make an informed and confident decision.

We also played a central role in managing the commercial sensitivities involved, while also leading negotiations on the terms of investment. This transaction exemplifies our commitment to delivering commercially astute legal advice, tailored to the strategic ambitions of clients.

A strategic partnership shaping the future of IVF treatments

This landmark investment significantly strengthens ReproTech’s position as a leader in cryostorage solutions by expanding its capabilities in traceability and digital safety. It also strengthens IMT Matcher’s market-leading position by enabling it to offer ReproTech’s portfolio of cryopreservation and expertise in risk-reduction. 

Together, the combined offering paves the way for the development of the first fully integrated, end-to-end secure digital platform for fertility patients and their specimens — enabling fertility clinics and patients to document and monitor every stage of the IVF journey with precision, while ensuring the highest standards of specimen safety and storage available in the market today.

Talk to us

Whatever your need, whatever your sector, if you’re considering a strategic partnership or exit strategy, our corporate and deal advisory experts are here to support at every stage.

Talk to our experts by giving us a call, sending us an email or completing our contact form below.